While familial cases of AD account for a small fraction of total cases [9], preclinical rodent models overwhelmingly rely on overexpression of human mutations associated with familial AD, including amyloid precursor protein (APP), presenilin-1 (PSEN1) and presenilin-2 (PSEN2) [10, 11]. The gene discussed is APP; the disease is Alzheimer disease.